Scientists test new prostate disease drug

A Canadian-headquartered biopharmaceutical company is conducting the second Phase 3 study of a new drug designed to treat prostate disease.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news125855861.html">Scientists test new prostate disease drug</a></p> <p>A Canadian-headquartered biopharmaceutical company is conducting the second Phase 3 study of a new drug designed to treat prostate disease. </p>